BAC
Bank of America Corporation
BAC has slightly lower modeled downside risk, despite its lower overall score.
ISTR
Investar Holding Corporation
ISTR has the edge over BAC overall, supported by stronger fundamentals.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
ISTR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
ISTR's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like ISTR.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over ISTR in the historical PE scenario, which offers more potential upside but is not a forecast.
ISTR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.7x | $17.54 | -38% |
| Forward | 9.1x | $28.15 | — |
| Current | 11x | $28.15 | — |
| Fair | 12x | $30.37 | +7.9% |
| Expensive | 14x | $37.39 | +33% |
Historical ranges are pointers, not guarantees.
ISTR's PE is in its fair range at 11x. If earnings grow as analysts expect, today's price would be 9.1x next year's earnings, in its cheap range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
ISTR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for ISTR, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over ISTR on earnings, with stronger typical year-over-year growth.
ISTR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.09 | +18% |
| Q3 2026 | $2.62 | +17% |
| Q2 2026 | $2.42 | +8% |
| Q1 2026 | $2.27 | +3.7% |
| Q4 2025 | $2.13 | +4.4% |
| Q3 2025 | $2.24 | +25% |
| Q2 2025 | $2.24 | +46% |
| Q1 2025 | $2.19 | +22% |
| Q4 2024 | $2.04 | +21% |
ISTR's earnings per share have fallen from their peak: $2.62 over the past year, against $3.50 in late 2022.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
ISTR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $36.8M | +53% |
| Q2 2026 | $36.5M | +65% |
| Q1 2026 | $35.6M | +49% |
| Q4 2025 | $23.5M | +0.9% |
| Q3 2025 | $24M | +7.4% |
| Q2 2025 | $22.1M | +8.7% |
| Q1 2025 | $24M | +12% |
| Q4 2024 | $23.3M | +18% |
ISTR has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 39% | +7.5 points |
| Q2 2026 | 32% | +7.2 points |
| Q1 2026 | 42% | +9.6 points |
| Q4 2025 | 31% | -0.3 points |
| Q3 2025 | 31% | +3.6 points |
| Q2 2025 | 25% | +0.5 points |
| Q1 2025 | 32% | +3.7 points |
| Q4 2024 | 31% | +9.3 points |
ISTR has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
ISTR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $11.1M | +60% |
| Q2 2026 | $6.4M | +103% |
| Q1 2026 | $9.9M | +122% |
| Q4 2025 | $3.6M | +$3.9M |
| Q3 2025 | $6.9M | +25% |
| Q2 2025 | $3.2M | +12% |
| Q1 2025 | $4.5M | -43% |
| Q4 2024 | -$291K | -198% |
ISTR has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over ISTR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
ISTR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.2% | +182K shares |
| 1 year | +58% | +5.8M shares |
| 3 years | +59% | +5.8M shares |
| 5 years | +49% | +5.2M shares |
| Available history | +57% | +5.7M shares |
ISTR has 16M diluted shares, up 58% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $747,000 |
| Q2 2026 | $763,000 |
| Q1 2026 | $1.5M |
| Q4 2025 | $689,000 |
| Q3 2025 | $321,000 |
| Q2 2025 | $634,000 |
| Q1 2025 | $649,000 |
| Q4 2024 | — |
ISTR spent $4M buying back its own shares over the past year, up 134% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
ISTR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.2x | Elevated |
| Q2 2026 | 2.7x | Moderate |
| Q1 2026 | 3.0x | Moderate |
| Q4 2025 | -0.6x | Net Cash |
| Q3 2025 | 1.4x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 1.7x | Healthy |
| Q4 2024 | -0.6x | Net Cash |
ISTR has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
ISTR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.5 | Neutral |
| Stochastic | 14.8 | Oversold |
ISTR's weekly RSI is 44 (neutral) and its Stochastic is 15 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
ISTR PE vs Financial Services Sector
| Metric | ISTR | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 18% below |
| PE % | 43 | 63 | 20 pts below |
ISTR has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
ISTR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $28.5 | 1.2% below |
| 20 week MA | $29.5 | 4.7% below |
| 50 week MA | $28.7 | 1.8% below |
| 100 week MA | $24.7 | 14% above |
| 200 week MA | $20.2 | 39% above |
ISTR has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
ISTR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $24.1 | $16.6 | -31% |
| 2021 | $16.6 | $17.8 | +6.8% |
| 2022 | $17.8 | $21.6 | +21% |
| 2023 | $21.6 | $14.9 | -31% |
| 2024 | $14.9 | $22.0 | +47% |
| 2025 | $22.0 | $27.3 | +24% |
| 2026 YTD | $27.3 | $28.2 | +3.2% |
ISTR has the edge over BAC on returns for 2026, with the stronger performance.